Article
Factbox: Companies in Alzheimer's race after US nod for Eisai/Biogen drug
Rating:
0.0
Views:
44
Likes:
1
Library:
1
Eisai Co Ltd and Biogen Inc's Leqembi emerged as the first Alzheimer's treatment to win the U.S. Food and Drug Administration's standard approval on Thursday, a milestone in drug development for a disease that has seen multiple failures in the past.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value